Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
4
×
biotech
alzheimer's disease
amgen
biogen
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
crispr
cystic fibrosis
detroit blog main
detroit top stories
diagnostics
glaxosmithkline
indiana blog main
indiana top stories
investing
jennifer doudna
mammoth biosciences
merck
messenger rna
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
What
bio
crispr
4
×
roundup
today
acquisitions
albert
alliance
available
based
big
biggest
biosciences
bourla
bristol
buy
calls
cas
ceo
changing
cheaper
color
company
create
days
develop
diagnostic
diagnostics
diseases
drug
editing
expects
faster
fix
future
gene
growing
heats
high
hours
human
Language
unset
unknown
Current search:
crispr
×
deals
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M